

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.30193562 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30193562 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.10138236 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.10138236 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.60628913 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01165929 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.01012858 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.01012858 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.01012858 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.72945393 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.68420783 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.63151096 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.54101633 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.32688672 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.29594280 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.20066198 |
| 17 | protein carboxylation (GO:0018214) | 5.15568856 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15568856 |
| 19 | cysteine metabolic process (GO:0006534) | 5.14212133 |
| 20 | urea cycle (GO:0000050) | 5.13447285 |
| 21 | urea metabolic process (GO:0019627) | 5.13447285 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.97355139 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95477451 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 4.81949852 |
| 25 | bile acid metabolic process (GO:0008206) | 4.79081282 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.77877071 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.76544587 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.74834152 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.71814148 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 4.67482540 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.65167542 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 4.53041544 |
| 33 | negative regulation of sterol transport (GO:0032372) | 4.53041544 |
| 34 | phospholipid efflux (GO:0033700) | 4.52311889 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 4.50922572 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.50906003 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.50764699 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.47972937 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.46755399 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41826384 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.41826384 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.41826384 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.39446902 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.39311719 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.39311719 |
| 46 | lysine catabolic process (GO:0006554) | 4.39011617 |
| 47 | lysine metabolic process (GO:0006553) | 4.39011617 |
| 48 | cellular glucuronidation (GO:0052695) | 4.34277790 |
| 49 | regulation of complement activation (GO:0030449) | 4.32965719 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.30182129 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.29994736 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.27924689 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.22290519 |
| 54 | aldehyde catabolic process (GO:0046185) | 4.21478376 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.18438604 |
| 56 | amine catabolic process (GO:0009310) | 4.17700340 |
| 57 | cellular biogenic amine catabolic process (GO:0042402) | 4.17700340 |
| 58 | protein retention in ER lumen (GO:0006621) | 4.10873622 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.09347224 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.05835788 |
| 61 | benzene-containing compound metabolic process (GO:0042537) | 4.02309387 |
| 62 | drug catabolic process (GO:0042737) | 4.02219232 |
| 63 | glucuronate metabolic process (GO:0019585) | 4.01841806 |
| 64 | uronic acid metabolic process (GO:0006063) | 4.01841806 |
| 65 | ethanol oxidation (GO:0006069) | 4.01390505 |
| 66 | glycine metabolic process (GO:0006544) | 3.97162077 |
| 67 | glutamate metabolic process (GO:0006536) | 3.94728092 |
| 68 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.93336423 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.90856213 |
| 70 | cholesterol efflux (GO:0033344) | 3.89742377 |
| 71 | ketone body metabolic process (GO:1902224) | 3.89373147 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 3.88726053 |
| 73 | flavonoid metabolic process (GO:0009812) | 3.86211623 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.85270768 |
| 75 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.83977819 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.75628445 |
| 77 | drug transmembrane transport (GO:0006855) | 3.74077439 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 3.72975635 |
| 79 | endothelial cell chemotaxis (GO:0035767) | 3.72758298 |
| 80 | arginine metabolic process (GO:0006525) | 3.72653004 |
| 81 | cofactor catabolic process (GO:0051187) | 3.70725309 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69878744 |
| 83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69878744 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.68881172 |
| 85 | organic acid catabolic process (GO:0016054) | 3.68881172 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 3.65349585 |
| 87 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.63748070 |
| 88 | fibrinolysis (GO:0042730) | 3.63568212 |
| 89 | urate metabolic process (GO:0046415) | 3.62196088 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.62076502 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61956747 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.59189967 |
| 93 | NAD biosynthetic process (GO:0009435) | 3.59010018 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.58303378 |
| 95 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55675950 |
| 96 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55675950 |
| 97 | virion attachment to host cell (GO:0019062) | 3.54371285 |
| 98 | adhesion of symbiont to host cell (GO:0044650) | 3.54371285 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.54091244 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 3.51012268 |
| 101 | monocarboxylic acid catabolic process (GO:0072329) | 3.50846870 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.50642077 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.50422537 |
| 104 | sterol homeostasis (GO:0055092) | 3.48166892 |
| 105 | fatty acid oxidation (GO:0019395) | 3.47321065 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 3.47136420 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.46819257 |
| 108 | adhesion of symbiont to host (GO:0044406) | 3.18046604 |
| 109 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.13123263 |
| 110 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.11756132 |
| 111 | actin filament depolymerization (GO:0030042) | 3.10090066 |
| 112 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.08762525 |
| 113 | barbed-end actin filament capping (GO:0051016) | 3.07598493 |
| 114 | GDP-mannose metabolic process (GO:0019673) | 3.02273396 |
| 115 | renal filtration (GO:0097205) | 3.00681669 |
| 116 | protein maturation by protein folding (GO:0022417) | 2.97380824 |
| 117 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.94622369 |
| 118 | lymph vessel development (GO:0001945) | 2.94581121 |
| 119 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92782534 |
| 120 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.88699330 |
| 121 | UV protection (GO:0009650) | 2.84286353 |
| 122 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.83987156 |
| 123 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.82586007 |
| 124 | basement membrane organization (GO:0071711) | 2.76568337 |
| 125 | endothelium development (GO:0003158) | 2.73649797 |
| 126 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.71623610 |
| 127 | regulation of plasminogen activation (GO:0010755) | 2.70003917 |
| 128 | extracellular fibril organization (GO:0043206) | 2.69404941 |
| 129 | positive regulation of pseudopodium assembly (GO:0031274) | 2.67876543 |
| 130 | positive regulation of protein kinase C signaling (GO:0090037) | 2.63346764 |
| 131 | hemidesmosome assembly (GO:0031581) | 2.63099036 |
| 132 | type B pancreatic cell proliferation (GO:0044342) | 2.62009682 |
| 133 | atrioventricular valve morphogenesis (GO:0003181) | 2.59746304 |
| 134 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.57735395 |
| 135 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.57686902 |
| 136 | glial cell migration (GO:0008347) | 2.57387654 |
| 137 | cell-substrate junction assembly (GO:0007044) | 2.56952586 |
| 138 | pattern specification involved in kidney development (GO:0061004) | 2.54797320 |
| 139 | epoxygenase P450 pathway (GO:0019373) | 2.53639524 |
| 140 | tonic smooth muscle contraction (GO:0014820) | 2.50416444 |
| 141 | glomerular filtration (GO:0003094) | 2.48156931 |
| 142 | macroautophagy (GO:0016236) | 2.48107471 |
| 143 | semaphorin-plexin signaling pathway (GO:0071526) | 2.46565684 |
| 144 | positive regulation of odontogenesis (GO:0042482) | 2.44420857 |
| 145 | COPI coating of Golgi vesicle (GO:0048205) | 2.44167760 |
| 146 | Golgi transport vesicle coating (GO:0048200) | 2.44167760 |
| 147 | negative regulation of cell size (GO:0045792) | 2.41271027 |
| 148 | ribosomal small subunit biogenesis (GO:0042274) | 2.40806048 |
| 149 | angiogenesis involved in wound healing (GO:0060055) | 2.39665578 |
| 150 | endocrine hormone secretion (GO:0060986) | 2.39407382 |
| 151 | venous blood vessel morphogenesis (GO:0048845) | 2.39177295 |
| 152 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.38373181 |
| 153 | renal system process involved in regulation of blood volume (GO:0001977) | 2.37667896 |
| 154 | positive regulation of vascular permeability (GO:0043117) | 2.37551400 |
| 155 | fibril organization (GO:0097435) | 2.36889632 |
| 156 | endocytic recycling (GO:0032456) | 2.34108907 |
| 157 | arginine catabolic process (GO:0006527) | 2.34059570 |
| 158 | negative regulation of fatty acid transport (GO:2000192) | 2.33917895 |
| 159 | regulation of pseudopodium assembly (GO:0031272) | 2.30195663 |
| 160 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.28680337 |
| 161 | adherens junction assembly (GO:0034333) | 2.28244945 |
| 162 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.27687836 |
| 163 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.27601113 |
| 164 | endocrine process (GO:0050886) | 2.27397575 |
| 165 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.27397575 |
| 166 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.27397575 |
| 167 | mitochondrial calcium ion transport (GO:0006851) | 2.27257754 |
| 168 | focal adhesion assembly (GO:0048041) | 2.26845570 |
| 169 | cell-substrate adherens junction assembly (GO:0007045) | 2.26845570 |
| 170 | regulation of cholesterol metabolic process (GO:0090181) | 2.25605867 |
| 171 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.25022488 |
| 172 | protein localization to endosome (GO:0036010) | 2.24159036 |
| 173 | adenosine receptor signaling pathway (GO:0001973) | 2.22858483 |
| 174 | positive regulation of cartilage development (GO:0061036) | 2.22839571 |
| 175 | regulation of endothelial cell differentiation (GO:0045601) | 2.22691090 |
| 176 | prostanoid biosynthetic process (GO:0046457) | 2.22404058 |
| 177 | prostaglandin biosynthetic process (GO:0001516) | 2.22404058 |
| 178 | apoptotic cell clearance (GO:0043277) | 2.22298766 |
| 179 | mannose metabolic process (GO:0006013) | 2.21457832 |
| 180 | artery smooth muscle contraction (GO:0014824) | 2.21091542 |
| 181 | proline biosynthetic process (GO:0006561) | 2.19739272 |
| 182 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.18622798 |
| 183 | endodermal cell differentiation (GO:0035987) | 2.18194640 |
| 184 | skin morphogenesis (GO:0043589) | 2.17983383 |
| 185 | Rho protein signal transduction (GO:0007266) | 2.17410145 |
| 186 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.16896701 |
| 187 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.16363512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.88731414 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.79160098 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.39326341 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.97539856 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.16683441 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.98778518 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.88044023 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.86276135 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.75029635 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.45588850 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96373603 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.71686652 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.64899324 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19314492 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.08061811 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05552618 |
| 17 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.04164181 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1740336 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90182235 |
| 20 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88286172 |
| 21 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.80798960 |
| 22 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.79789520 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 1.78419125 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78244100 |
| 25 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.72897173 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71542220 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.70182456 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64457830 |
| 29 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63849021 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62779701 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61934382 |
| 32 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58198911 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57854513 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56900542 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55507264 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55456949 |
| 37 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.54618564 |
| 38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51212880 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49760123 |
| 40 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.47517575 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42151499 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41306267 |
| 43 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40721903 |
| 44 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.40665167 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38338561 |
| 46 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37983278 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.37079947 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36586176 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36031731 |
| 50 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.34477199 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32564766 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29097405 |
| 53 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.28154976 |
| 54 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.27748118 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27633038 |
| 56 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27404109 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26668815 |
| 58 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26534485 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26364468 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22276531 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22064701 |
| 62 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.19494325 |
| 63 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18763063 |
| 64 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.16915280 |
| 65 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16127373 |
| 66 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.14971337 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14754467 |
| 68 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11235687 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10913648 |
| 70 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10612415 |
| 71 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10501481 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09672249 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09447560 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09304047 |
| 75 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08752045 |
| 76 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07149033 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06196796 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05350004 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05183450 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05113567 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03595265 |
| 82 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03183573 |
| 83 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02900539 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01297950 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00826413 |
| 86 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00786111 |
| 87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00271657 |
| 88 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00049368 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99565535 |
| 90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99053508 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.98882410 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98156583 |
| 93 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98115098 |
| 94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97904309 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97253053 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96970220 |
| 97 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.96882560 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96059821 |
| 99 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95838178 |
| 100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94548008 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94505279 |
| 102 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.94277211 |
| 103 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92225147 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90005477 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87783471 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87543235 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81950337 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81007618 |
| 109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80787434 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79444956 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77745118 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76776262 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76111546 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74864157 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72820566 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72041561 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.71616458 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70918489 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70905865 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69602903 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69308943 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69015116 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.68628324 |
| 124 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67143080 |
| 125 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66074832 |
| 126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65980068 |
| 127 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65261333 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63811631 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63724280 |
| 130 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63217817 |
| 131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63057164 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62083764 |
| 133 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.61429933 |
| 134 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.61205460 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61157070 |
| 136 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.60598911 |
| 137 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.59957867 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59848827 |
| 139 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59415778 |
| 140 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58267360 |
| 141 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58021562 |
| 142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57723169 |
| 143 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57232225 |
| 144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57163518 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56694912 |
| 146 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.56655703 |
| 147 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56357586 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55667533 |
| 149 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.54816065 |
| 150 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53901626 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53674268 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53674268 |
| 153 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52159422 |
| 154 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.50836057 |
| 155 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50788249 |
| 156 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50023157 |
| 157 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.49488355 |
| 158 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49159203 |
| 159 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48218161 |
| 160 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.48134792 |
| 161 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.47654513 |
| 162 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.47085085 |
| 163 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.46875663 |
| 164 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46481996 |
| 165 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.46327429 |
| 166 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46286516 |
| 167 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.46161374 |
| 168 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.45773658 |
| 169 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.45721876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15100561 |
| 2 | MP0005360_urolithiasis | 7.27788695 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.94248319 |
| 4 | MP0005365_abnormal_bile_salt | 5.83622606 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.80359157 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.12541229 |
| 7 | MP0003252_abnormal_bile_duct | 3.66483024 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.38141813 |
| 9 | MP0009840_abnormal_foam_cell | 3.24548220 |
| 10 | MP0000013_abnormal_adipose_tissue | 3.19215669 |
| 11 | MP0005083_abnormal_biliary_tract | 2.94124640 |
| 12 | MP0004272_abnormal_basement_membrane | 2.83717577 |
| 13 | MP0005332_abnormal_amino_acid | 2.76738492 |
| 14 | MP0003195_calcinosis | 2.76471271 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.59787267 |
| 16 | MP0000003_abnormal_adipose_tissue | 2.56193345 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.55531470 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.48152049 |
| 19 | MP0001958_emphysema | 2.35744072 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.33610441 |
| 21 | MP0003279_aneurysm | 2.27052298 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.20155324 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.19287696 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 2.13884201 |
| 25 | MP0005375_adipose_tissue_phenotype | 2.12798470 |
| 26 | MP0000609_abnormal_liver_physiology | 2.08607976 |
| 27 | MP0005666_abnormal_adipose_tissue | 2.05602879 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 2.05270989 |
| 29 | MP0003566_abnormal_cell_adhesion | 2.03203618 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.98321727 |
| 31 | MP0005623_abnormal_meninges_morphology | 1.96124515 |
| 32 | MP0003868_abnormal_feces_composition | 1.87444331 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.85642852 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.79002412 |
| 35 | MP0009384_cardiac_valve_regurgitation | 1.73092272 |
| 36 | MP0000751_myopathy | 1.66782794 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66131850 |
| 38 | MP0001764_abnormal_homeostasis | 1.66035276 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.60589028 |
| 40 | MP0005023_abnormal_wound_healing | 1.56875053 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.55762534 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.53025206 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.51739836 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.49137844 |
| 45 | MP0000343_altered_response_to | 1.47740351 |
| 46 | MP0005330_cardiomyopathy | 1.47322244 |
| 47 | MP0009697_abnormal_copulation | 1.47124921 |
| 48 | MP0003879_abnormal_hair_cell | 1.46471172 |
| 49 | MP0003186_abnormal_redox_activity | 1.45119356 |
| 50 | MP0005451_abnormal_body_composition | 1.40316619 |
| 51 | MP0004510_myositis | 1.36781280 |
| 52 | MP0006138_congestive_heart_failure | 1.33138511 |
| 53 | MP0009764_decreased_sensitivity_to | 1.20854628 |
| 54 | MP0000767_abnormal_smooth_muscle | 1.19607263 |
| 55 | MP0000598_abnormal_liver_morphology | 1.16767398 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.16030547 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.14922536 |
| 58 | MP0005595_abnormal_vascular_smooth | 1.14494903 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.13326577 |
| 60 | MP0005508_abnormal_skeleton_morphology | 1.11408002 |
| 61 | MP0005409_darkened_coat_color | 1.11261093 |
| 62 | MP0008469_abnormal_protein_level | 1.11101090 |
| 63 | MP0005501_abnormal_skin_physiology | 1.10480924 |
| 64 | MP0005165_increased_susceptibility_to | 1.09399322 |
| 65 | MP0003011_delayed_dark_adaptation | 1.09374869 |
| 66 | MP0003091_abnormal_cell_migration | 1.07835405 |
| 67 | MP0002932_abnormal_joint_morphology | 1.07499127 |
| 68 | MP0002249_abnormal_larynx_morphology | 1.07407934 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 1.07073252 |
| 70 | MP0009763_increased_sensitivity_to | 1.05815730 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.05174127 |
| 72 | MP0005647_abnormal_sex_gland | 1.03551405 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.02534994 |
| 74 | MP0000604_amyloidosis | 0.99226781 |
| 75 | MP0002060_abnormal_skin_morphology | 0.96844677 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.96083492 |
| 77 | MP0000762_abnormal_tongue_morphology | 0.94595663 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.94583636 |
| 79 | MP0005464_abnormal_platelet_physiology | 0.93143766 |
| 80 | MP0008004_abnormal_stomach_pH | 0.93095379 |
| 81 | MP0001849_ear_inflammation | 0.92311459 |
| 82 | MP0005408_hypopigmentation | 0.91892315 |
| 83 | MP0000750_abnormal_muscle_regeneration | 0.91257774 |
| 84 | MP0002933_joint_inflammation | 0.90542073 |
| 85 | MP0001664_abnormal_digestion | 0.90474799 |
| 86 | MP0000467_abnormal_esophagus_morphology | 0.88836437 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.87855699 |
| 88 | MP0003436_decreased_susceptibility_to | 0.87704109 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.87621640 |
| 90 | MP0002796_impaired_skin_barrier | 0.87221237 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.85867865 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.85762588 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.85047692 |
| 94 | MP0003724_increased_susceptibility_to | 0.84244738 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.84083573 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.83212248 |
| 97 | MP0009053_abnormal_anal_canal | 0.81509319 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.81353218 |
| 99 | MP0003828_pulmonary_edema | 0.80893230 |
| 100 | MP0005535_abnormal_body_temperature | 0.79328909 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.79202758 |
| 102 | MP0005275_abnormal_skin_tensile | 0.78878158 |
| 103 | MP0005670_abnormal_white_adipose | 0.78563912 |
| 104 | MP0001348_abnormal_lacrimal_gland | 0.77527426 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.77262436 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 0.76743334 |
| 107 | MP0005334_abnormal_fat_pad | 0.76360916 |
| 108 | MP0004858_abnormal_nervous_system | 0.75582582 |
| 109 | MP0001756_abnormal_urination | 0.75571904 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.75483092 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.75300494 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.74292021 |
| 113 | MP0000163_abnormal_cartilage_morphology | 0.74076477 |
| 114 | MP0002928_abnormal_bile_duct | 0.73153492 |
| 115 | MP0001542_abnormal_bone_strength | 0.73144429 |
| 116 | MP0000733_abnormal_muscle_development | 0.73072938 |
| 117 | MP0003385_abnormal_body_wall | 0.70832746 |
| 118 | MP0001188_hyperpigmentation | 0.70713942 |
| 119 | MP0002254_reproductive_system_inflammat | 0.70579587 |
| 120 | MP0000462_abnormal_digestive_system | 0.69536015 |
| 121 | MP0001270_distended_abdomen | 0.68947265 |
| 122 | MP0002971_abnormal_brown_adipose | 0.68930932 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.68388169 |
| 124 | MP0001614_abnormal_blood_vessel | 0.68216649 |
| 125 | MP0003283_abnormal_digestive_organ | 0.67523067 |
| 126 | MP0004130_abnormal_muscle_cell | 0.66832459 |
| 127 | MP0009785_altered_susceptibility_to | 0.64275088 |
| 128 | MP0006082_CNS_inflammation | 0.63026370 |
| 129 | MP0001661_extended_life_span | 0.61877062 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.61735079 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.61073426 |
| 132 | MP0005266_abnormal_metabolism | 0.60992217 |
| 133 | MP0005448_abnormal_energy_balance | 0.59906255 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.56597273 |
| 135 | MP0005025_abnormal_response_to | 0.55092273 |
| 136 | MP0000685_abnormal_immune_system | 0.52521101 |
| 137 | MP0001835_abnormal_antigen_presentation | 0.51483618 |
| 138 | MP0008874_decreased_physiological_sensi | 0.51301253 |
| 139 | MP0001853_heart_inflammation | 0.51181650 |
| 140 | MP0002419_abnormal_innate_immunity | 0.49914924 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.49735865 |
| 142 | MP0003075_altered_response_to | 0.49015863 |
| 143 | MP0003953_abnormal_hormone_level | 0.48819145 |
| 144 | MP0003690_abnormal_glial_cell | 0.48111789 |
| 145 | MP0008873_increased_physiological_sensi | 0.47567487 |
| 146 | MP0005166_decreased_susceptibility_to | 0.47396508 |
| 147 | MP0003300_gastrointestinal_ulcer | 0.46148337 |
| 148 | MP0004043_abnormal_pH_regulation | 0.46054432 |
| 149 | MP0003329_amyloid_beta_deposits | 0.45354216 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.45134132 |
| 151 | MP0004947_skin_inflammation | 0.44346177 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.42901069 |
| 153 | MP0001765_abnormal_ion_homeostasis | 0.42655105 |
| 154 | MP0010155_abnormal_intestine_physiology | 0.41091956 |
| 155 | MP0000249_abnormal_blood_vessel | 0.38790188 |
| 156 | MP0004381_abnormal_hair_follicle | 0.36907078 |
| 157 | MP0001944_abnormal_pancreas_morphology | 0.36828723 |
| 158 | MP0005075_abnormal_melanosome_morpholog | 0.36621093 |
| 159 | MP0002970_abnormal_white_adipose | 0.35569845 |
| 160 | MP0008872_abnormal_physiological_respon | 0.34763111 |
| 161 | MP0002135_abnormal_kidney_morphology | 0.33644834 |
| 162 | MP0004147_increased_porphyrin_level | 0.33517160 |
| 163 | MP0005387_immune_system_phenotype | 0.33252169 |
| 164 | MP0001790_abnormal_immune_system | 0.33252169 |
| 165 | MP0000538_abnormal_urinary_bladder | 0.33156939 |
| 166 | MP0003172_abnormal_lysosome_physiology | 0.32509070 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.32114912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.36708041 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.55668429 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.48489389 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00180921 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.88119890 |
| 6 | Xanthomatosis (HP:0000991) | 5.84219465 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.82970314 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.23147533 |
| 9 | Joint hemorrhage (HP:0005261) | 4.65179275 |
| 10 | Complement deficiency (HP:0004431) | 4.51537102 |
| 11 | Protrusio acetabuli (HP:0003179) | 4.41047038 |
| 12 | Hyperammonemia (HP:0001987) | 4.28988052 |
| 13 | Ketosis (HP:0001946) | 4.27675721 |
| 14 | Premature rupture of membranes (HP:0001788) | 4.21127996 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.18973001 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11864102 |
| 17 | Hypoglycemic coma (HP:0001325) | 4.11247469 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.07935029 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.97088759 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96841293 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.91338598 |
| 22 | Hyperglycinemia (HP:0002154) | 3.91302003 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.88877817 |
| 24 | Epidermoid cyst (HP:0200040) | 3.73308968 |
| 25 | Fat malabsorption (HP:0002630) | 3.73086663 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70488283 |
| 27 | Hyperglycinuria (HP:0003108) | 3.66951238 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63401852 |
| 29 | Vertebral compression fractures (HP:0002953) | 3.61350734 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.59670018 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.59670018 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58881646 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.53182560 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.52296715 |
| 35 | Cervical subluxation (HP:0003308) | 3.41505180 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.34761272 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.33991571 |
| 38 | Abnormality of complement system (HP:0005339) | 3.32663652 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.23707953 |
| 40 | Joint stiffness (HP:0001387) | 3.23094598 |
| 41 | Ketoacidosis (HP:0001993) | 3.20619454 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.11908078 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04753080 |
| 44 | Hypoglycemic seizures (HP:0002173) | 2.96644899 |
| 45 | Atrophic scars (HP:0001075) | 2.94792315 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.93420513 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.93420513 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.89748984 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.89414541 |
| 50 | Axonal loss (HP:0003447) | 2.82342818 |
| 51 | Metabolic acidosis (HP:0001942) | 2.80190814 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.79426856 |
| 53 | Gout (HP:0001997) | 2.77692006 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.76443906 |
| 55 | Distal lower limb amyotrophy (HP:0008944) | 2.76328269 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74318631 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74318631 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74318631 |
| 59 | Steatorrhea (HP:0002570) | 2.74027071 |
| 60 | Shallow orbits (HP:0000586) | 2.71670092 |
| 61 | Myocardial infarction (HP:0001658) | 2.71140132 |
| 62 | J-shaped sella turcica (HP:0002680) | 2.71012435 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.70558227 |
| 64 | Spontaneous abortion (HP:0005268) | 2.65633452 |
| 65 | Broad face (HP:0000283) | 2.62743658 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.61087105 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61087105 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.60594967 |
| 69 | Lethargy (HP:0001254) | 2.60245033 |
| 70 | Nuclear cataract (HP:0100018) | 2.59214102 |
| 71 | Short nail (HP:0001799) | 2.57571341 |
| 72 | Vascular calcification (HP:0004934) | 2.57443833 |
| 73 | Fragile skin (HP:0001030) | 2.56590026 |
| 74 | Menorrhagia (HP:0000132) | 2.51705370 |
| 75 | Achilles tendon contracture (HP:0001771) | 2.51265181 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.51065117 |
| 77 | Abnormality of the Achilles tendon (HP:0005109) | 2.50649658 |
| 78 | Gingival bleeding (HP:0000225) | 2.50564473 |
| 79 | Glomerulonephritis (HP:0000099) | 2.49237924 |
| 80 | Aortic aneurysm (HP:0004942) | 2.48729420 |
| 81 | Spinal rigidity (HP:0003306) | 2.46738832 |
| 82 | Increased variability in muscle fiber diameter (HP:0003557) | 2.46217851 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.43896328 |
| 84 | Cerebral edema (HP:0002181) | 2.43866497 |
| 85 | Skin nodule (HP:0200036) | 2.43107265 |
| 86 | Late onset (HP:0003584) | 2.41000797 |
| 87 | Amyloidosis (HP:0011034) | 2.39710534 |
| 88 | Symptomatic seizures (HP:0011145) | 2.34568801 |
| 89 | Irritability (HP:0000737) | 2.34228177 |
| 90 | Mitral stenosis (HP:0001718) | 2.30724292 |
| 91 | Stridor (HP:0010307) | 2.30211595 |
| 92 | Testicular atrophy (HP:0000029) | 2.30129965 |
| 93 | Malnutrition (HP:0004395) | 2.29955276 |
| 94 | Neonatal onset (HP:0003623) | 2.29704346 |
| 95 | Acanthosis nigricans (HP:0000956) | 2.28898341 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.28776960 |
| 97 | Hypertriglyceridemia (HP:0002155) | 2.26532342 |
| 98 | Pancreatitis (HP:0001733) | 2.25810998 |
| 99 | Thin bony cortex (HP:0002753) | 2.24280255 |
| 100 | Opisthotonus (HP:0002179) | 2.22054160 |
| 101 | Growth hormone excess (HP:0000845) | 2.21117113 |
| 102 | Vomiting (HP:0002013) | 2.21058808 |
| 103 | Brushfield spots (HP:0001088) | 2.20957633 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20501278 |
| 105 | Acanthocytosis (HP:0001927) | 2.20419837 |
| 106 | Cerebral aneurysm (HP:0004944) | 2.20299500 |
| 107 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20177209 |
| 108 | Wormian bones (HP:0002645) | 2.20086580 |
| 109 | Aortic regurgitation (HP:0001659) | 2.18988131 |
| 110 | Aortic dissection (HP:0002647) | 2.17036654 |
| 111 | Esophageal varix (HP:0002040) | 2.13982478 |
| 112 | Glycosuria (HP:0003076) | 2.13433299 |
| 113 | Abnormality of urine glucose concentration (HP:0011016) | 2.13433299 |
| 114 | Difficulty climbing stairs (HP:0003551) | 2.13150362 |
| 115 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.11961399 |
| 116 | Ulnar bowing (HP:0003031) | 2.11364305 |
| 117 | Distal upper limb amyotrophy (HP:0007149) | 2.10402670 |
| 118 | Upper limb amyotrophy (HP:0009129) | 2.10402670 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.09837449 |
| 120 | Thrombophlebitis (HP:0004418) | 2.08562178 |
| 121 | Alkalosis (HP:0001948) | 2.08451834 |
| 122 | Ileus (HP:0002595) | 2.08380110 |
| 123 | Sensorimotor neuropathy (HP:0007141) | 2.08075969 |
| 124 | Hydroxyprolinuria (HP:0003080) | 2.07985726 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 2.07985726 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07014643 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07014643 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07014643 |
| 129 | Spastic diplegia (HP:0001264) | 2.04343337 |
| 130 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.04228495 |
| 131 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.03754673 |
| 132 | Cholelithiasis (HP:0001081) | 2.02355769 |
| 133 | Increased connective tissue (HP:0009025) | 2.01935383 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01237053 |
| 135 | Proximal tubulopathy (HP:0000114) | 2.01109426 |
| 136 | Enlarged kidneys (HP:0000105) | 1.98908980 |
| 137 | Round ear (HP:0100830) | 1.98774855 |
| 138 | Interstitial pulmonary disease (HP:0006530) | 1.98357692 |
| 139 | Broad metatarsal (HP:0001783) | 1.97685253 |
| 140 | Bronchomalacia (HP:0002780) | 1.94973307 |
| 141 | Vascular tortuosity (HP:0004948) | 1.94407592 |
| 142 | Bowed forearm bones (HP:0003956) | 1.94339520 |
| 143 | Bowing of the arm (HP:0006488) | 1.94339520 |
| 144 | Stroke (HP:0001297) | 1.94232034 |
| 145 | Rickets (HP:0002748) | 1.93390637 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93032820 |
| 147 | Obstructive sleep apnea (HP:0002870) | 1.91475586 |
| 148 | Trismus (HP:0000211) | 1.90481152 |
| 149 | Mitral regurgitation (HP:0001653) | 1.89872167 |
| 150 | Arterial tortuosity (HP:0005116) | 1.88902123 |
| 151 | Cholecystitis (HP:0001082) | 1.88654961 |
| 152 | Abnormal gallbladder physiology (HP:0012438) | 1.88654961 |
| 153 | Elevated hepatic transaminases (HP:0002910) | 1.88580618 |
| 154 | Short clavicles (HP:0000894) | 1.86132914 |
| 155 | Blue sclerae (HP:0000592) | 1.85648631 |
| 156 | Abnormality of iron homeostasis (HP:0011031) | 1.84998021 |
| 157 | Renal cortical cysts (HP:0000803) | 1.84958779 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.84895705 |
| 159 | Hyperparathyroidism (HP:0000843) | 1.84538016 |
| 160 | Bradycardia (HP:0001662) | 1.84095580 |
| 161 | Bladder diverticulum (HP:0000015) | 1.83618192 |
| 162 | Hyperuricemia (HP:0002149) | 1.83310611 |
| 163 | Increased purine levels (HP:0004368) | 1.83310611 |
| 164 | Ankle contracture (HP:0006466) | 1.82977848 |
| 165 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82140721 |
| 166 | Rectal prolapse (HP:0002035) | 1.81920728 |
| 167 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.81282663 |
| 168 | Biconcave vertebral bodies (HP:0004586) | 1.78921824 |
| 169 | Epistaxis (HP:0000421) | 1.77767570 |
| 170 | Abnormal cartilage morphology (HP:0002763) | 1.77330487 |
| 171 | Wrist flexion contracture (HP:0001239) | 1.77210270 |
| 172 | Insulin resistance (HP:0000855) | 1.76919897 |
| 173 | Polycythemia (HP:0001901) | 1.76332503 |
| 174 | Aortic valve stenosis (HP:0001650) | 1.75304819 |
| 175 | Natal tooth (HP:0000695) | 1.74708486 |
| 176 | Elbow flexion contracture (HP:0002987) | 1.72923407 |
| 177 | Turricephaly (HP:0000262) | 1.71918115 |
| 178 | Atrioventricular block (HP:0001678) | 1.68759618 |
| 179 | Neonatal short-limb short stature (HP:0008921) | 1.68125090 |
| 180 | Atelectasis (HP:0100750) | 1.67717005 |
| 181 | Hydroureter (HP:0000072) | 1.66967031 |
| 182 | Exercise-induced myalgia (HP:0003738) | 1.66719592 |
| 183 | Asymmetric septal hypertrophy (HP:0001670) | 1.66715452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.10754500 |
| 2 | ERN1 | 4.46354314 |
| 3 | FGFR4 | 4.10935056 |
| 4 | SIK1 | 3.84338861 |
| 5 | EPHA2 | 3.26702990 |
| 6 | TESK1 | 3.22611798 |
| 7 | EPHB2 | 2.89353180 |
| 8 | TAOK3 | 2.77509747 |
| 9 | TYK2 | 2.46460345 |
| 10 | INSRR | 2.37324676 |
| 11 | FLT3 | 2.31802992 |
| 12 | PRKD2 | 2.14906095 |
| 13 | TRIB3 | 2.07876316 |
| 14 | MAPK15 | 1.99131765 |
| 15 | TESK2 | 1.98083079 |
| 16 | TTN | 1.96269518 |
| 17 | ARAF | 1.95495058 |
| 18 | MST1R | 1.95246812 |
| 19 | PKN2 | 1.93289008 |
| 20 | PIK3CG | 1.82141487 |
| 21 | TBK1 | 1.82106187 |
| 22 | NTRK1 | 1.78575697 |
| 23 | MAP3K6 | 1.73591222 |
| 24 | MAP2K4 | 1.62024636 |
| 25 | LIMK1 | 1.58083836 |
| 26 | PTK6 | 1.54212216 |
| 27 | KDR | 1.53283994 |
| 28 | MAPK11 | 1.48357336 |
| 29 | ICK | 1.46697703 |
| 30 | ERBB4 | 1.43978284 |
| 31 | NEK9 | 1.41144323 |
| 32 | PINK1 | 1.33885045 |
| 33 | MAP2K3 | 1.28580421 |
| 34 | TGFBR2 | 1.27941880 |
| 35 | MAP3K7 | 1.27488920 |
| 36 | EPHB1 | 1.27451525 |
| 37 | CAMK1D | 1.26824480 |
| 38 | CDC42BPA | 1.26350840 |
| 39 | DAPK3 | 1.24620961 |
| 40 | MAP4K1 | 1.22838267 |
| 41 | JAK1 | 1.19968183 |
| 42 | PDGFRA | 1.19770037 |
| 43 | IRAK3 | 1.19277860 |
| 44 | KIT | 1.18698848 |
| 45 | MAP3K14 | 1.18109152 |
| 46 | MAPKAPK3 | 1.16543712 |
| 47 | ILK | 1.16455342 |
| 48 | TLK1 | 1.15652867 |
| 49 | IKBKE | 1.15580056 |
| 50 | JAK2 | 1.14744466 |
| 51 | ABL2 | 1.14199171 |
| 52 | MARK2 | 1.11890470 |
| 53 | TAOK1 | 1.11112166 |
| 54 | NME2 | 1.08913708 |
| 55 | ZAP70 | 1.08799951 |
| 56 | PAK4 | 1.07740351 |
| 57 | RPS6KA2 | 1.03002469 |
| 58 | CSK | 1.01687521 |
| 59 | BTK | 1.00119244 |
| 60 | MAPK4 | 0.99873434 |
| 61 | TIE1 | 0.98429098 |
| 62 | LMTK2 | 0.98414716 |
| 63 | MAP3K11 | 0.97760855 |
| 64 | SMG1 | 0.95028576 |
| 65 | PRKAA2 | 0.94807477 |
| 66 | STK38 | 0.93184889 |
| 67 | DDR2 | 0.91223144 |
| 68 | EPHA3 | 0.89790140 |
| 69 | CSF1R | 0.88910910 |
| 70 | MAP2K6 | 0.88344304 |
| 71 | PAK2 | 0.86003036 |
| 72 | MAP2K2 | 0.85129386 |
| 73 | GRK6 | 0.84965600 |
| 74 | NME1 | 0.84860523 |
| 75 | MAP3K10 | 0.84569577 |
| 76 | DMPK | 0.83372399 |
| 77 | BLK | 0.82989149 |
| 78 | MAP3K3 | 0.82137085 |
| 79 | MATK | 0.78004791 |
| 80 | PRKD1 | 0.77824949 |
| 81 | DAPK2 | 0.77820345 |
| 82 | PRKD3 | 0.77284449 |
| 83 | PDPK1 | 0.76137735 |
| 84 | MOS | 0.75689895 |
| 85 | CAMK1G | 0.74639697 |
| 86 | JAK3 | 0.74510860 |
| 87 | RIPK1 | 0.73254493 |
| 88 | PRKG2 | 0.73219894 |
| 89 | TAOK2 | 0.73141022 |
| 90 | MTOR | 0.72471597 |
| 91 | LATS2 | 0.72276441 |
| 92 | IKBKB | 0.71956368 |
| 93 | TEC | 0.69538252 |
| 94 | ITK | 0.67083651 |
| 95 | PRKCZ | 0.67050979 |
| 96 | BMX | 0.66426466 |
| 97 | DYRK1B | 0.66061166 |
| 98 | RPS6KC1 | 0.65929481 |
| 99 | RPS6KL1 | 0.65929481 |
| 100 | ROCK1 | 0.65893595 |
| 101 | PRPF4B | 0.64932106 |
| 102 | SYK | 0.61806490 |
| 103 | MAPK12 | 0.61410290 |
| 104 | ERBB2 | 0.61283206 |
| 105 | PRKACG | 0.60633057 |
| 106 | FRK | 0.60136142 |
| 107 | AURKA | 0.59278962 |
| 108 | PDK1 | 0.58978185 |
| 109 | GSK3A | 0.56766828 |
| 110 | MAP3K13 | 0.56480271 |
| 111 | PTK2 | 0.56229357 |
| 112 | HIPK2 | 0.56031050 |
| 113 | IRAK4 | 0.54389387 |
| 114 | FGFR3 | 0.54343720 |
| 115 | LRRK2 | 0.50824239 |
| 116 | MYLK | 0.50418626 |
| 117 | MAP4K2 | 0.50020044 |
| 118 | CAMK4 | 0.49850086 |
| 119 | BRAF | 0.49782963 |
| 120 | MAPK7 | 0.49681463 |
| 121 | RPS6KA6 | 0.49501968 |
| 122 | CSNK1G1 | 0.48889384 |
| 123 | PAK1 | 0.48252861 |
| 124 | ADRBK2 | 0.47218582 |
| 125 | LYN | 0.46628391 |
| 126 | CAMK2G | 0.46060344 |
| 127 | CDK8 | 0.46041440 |
| 128 | PRKCI | 0.44886704 |
| 129 | CDK6 | 0.44443939 |
| 130 | RET | 0.44124303 |
| 131 | ADRBK1 | 0.43702708 |
| 132 | CAMK2D | 0.42787080 |
| 133 | PRKAA1 | 0.42459099 |
| 134 | TXK | 0.41959690 |
| 135 | IGF1R | 0.40643536 |
| 136 | SIK2 | 0.39999339 |
| 137 | IRAK1 | 0.39781559 |
| 138 | PRKCQ | 0.38388628 |
| 139 | CHUK | 0.38286000 |
| 140 | MAP3K1 | 0.37509435 |
| 141 | CDK9 | 0.37087660 |
| 142 | PAK6 | 0.37022111 |
| 143 | GRK1 | 0.36579673 |
| 144 | GRK5 | 0.36345615 |
| 145 | SIK3 | 0.36073362 |
| 146 | PIM2 | 0.34921596 |
| 147 | CSNK1G3 | 0.34874850 |
| 148 | SRC | 0.34641603 |
| 149 | PIK3CA | 0.33652897 |
| 150 | ROCK2 | 0.33646152 |
| 151 | PHKG2 | 0.32466126 |
| 152 | PHKG1 | 0.32466126 |
| 153 | MET | 0.32369981 |
| 154 | MAPK3 | 0.31437822 |
| 155 | AKT2 | 0.30492113 |
| 156 | MAP2K1 | 0.30082888 |
| 157 | CAMKK2 | 0.29808554 |
| 158 | MAP3K5 | 0.29802600 |
| 159 | PIM1 | 0.28680796 |
| 160 | PKN1 | 0.28221713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26780786 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.56260458 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35683003 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86735176 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79650628 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73981356 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69037401 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57275403 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56660463 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51935203 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46264225 |
| 12 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45083905 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33937779 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.22397714 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21386648 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13653474 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00105528 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97460045 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.93946840 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92550754 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91949310 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90304624 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.89927143 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85920020 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84165467 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78687076 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76875422 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73868480 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73654446 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72816100 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69209560 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67911150 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.62032348 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60905367 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58812635 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56728115 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.56517452 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50047256 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.48461233 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47286812 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42675376 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40850562 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.39600599 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37287468 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36897604 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35708753 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32810951 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.32056084 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.28699799 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 1.25220809 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24760941 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15473433 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14940749 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14447914 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11967369 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05258973 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04918275 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01971992 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01785719 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00200611 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99580534 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.99572695 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.98392175 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98092383 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92330376 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92090554 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91613766 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91485129 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90987096 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.86230135 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81728906 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79786438 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.77110545 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.73917094 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72425535 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72015010 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68376410 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67802938 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66969710 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.64340153 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63091889 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62180639 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61165500 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60936614 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.60033553 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.55612926 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54969290 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53907330 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52547514 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.50439041 |
| 91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50287748 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46000193 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45768783 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45744721 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45432502 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43811654 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42488083 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39970665 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38596310 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37953922 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.37752462 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36406496 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.34162978 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32880285 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.29220244 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.28984390 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28080130 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25636400 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24887842 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21444645 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10474385 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10314561 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09292573 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07513379 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04685931 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1886843 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1824634 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1706165 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1673775 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1628694 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1458638 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1428803 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1285903 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1149920 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1131530 |
| 126 | Pertussis_Homo sapiens_hsa05133 | -0.1017417 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0996491 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0849566 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0845188 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0711092 |
| 131 | Lysosome_Homo sapiens_hsa04142 | -0.0567794 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0132626 |
| 133 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0112940 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0061879 |

